Golden has been acquired by ComplyAdvantage.Read about it here ⟶

Entegrion, Inc.

Entegrion develops biologic and medical device technologies, such as a novel point of care in vitro diagnostic viscoelastic blood coagulation monitoring system for use in human and veterinary medicine.

Overview Structured Data Issues Contributors Activity

entegrion.com

Is a

Organization

Company

Company attributes

Industry

Consumer biotechnology

Location

Durham, North Carolina

CEO

‌

Bert Valada

Pitchbook URL

pitchbook.com/profiles.../58231-72

Email Address

info@entegrion.com0

Phone Number

+191953615000

Full Address

Imperial Business Park 4819 Emperor Boulevard, Suite 400 Durham, NC 277030

CIK Number

1,392,253

Investors

Sway Ventures

Founded Date

January 1, 2002

Fax Number

+191953617000

Total Funding Amount (USD)

20,000,000

Latest Funding Round Date

July 5, 2022

Patents Assigned (Count)

Country

United States

Other attributes

Company Operating Status

Active

Latest Funding Round Amount (USD)

20,000,000

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Entegrion, Inc.

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API